RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank38
Year-over-Year Change
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% vs avg
Percentile
P38
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
-54943.26%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -32.88% |
| Q4 2024 | 0.00% |
| Q3 2024 | 215.33% |
| Q2 2024 | 0.00% |
| Q1 2024 | 1142.55% |
| Q4 2023 | 0.00% |
| Q3 2023 | -95.25% |
| Q2 2023 | -50.18% |
| Q1 2023 | -52.69% |
| Q4 2022 | -48.15% |
| Q3 2022 | -13.37% |
| Q2 2022 | 37.29% |
| Q1 2022 | 148.85% |
| Q4 2021 | -77.89% |
| Q3 2021 | 13.45% |
| Q2 2021 | 5.72% |
| Q1 2021 | -4.51% |
| Q4 2020 | 1.91% |
| Q3 2020 | 58.04% |
| Q2 2020 | 1118.36% |
| Q1 2020 | -182.17% |
| Q4 2019 | 3.89% |
| Q3 2019 | -32.16% |
| Q2 2019 | -13.79% |
| Q1 2019 | 70.32% |
| Q4 2018 | -51.80% |
| Q3 2018 | -1.05% |
| Q2 2018 | 7.26% |
| Q1 2018 | 40.02% |
| Q4 2017 | 84.01% |
| Q3 2017 | 178.67% |
| Q2 2017 | 0.00% |
| Q1 2017 | 100.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | -100.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 100.00% |
| Q4 2015 | -2200300.00% |
| Q3 2015 | 0.00% |